Effect of Comt Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia

NeuroMolecular Medicine

Volumn 16, Issue 2, 2014, Pages 398-404

  Yamada, Kenji ^a   Shinkai, Takahiro ^a   Chen, Hsin I ^a,b   Utsunomiya, Kensuke ^a,c   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Principal office medical center   (Japan)

Author keywords

Catechol O methyltransferase; Pharmacogenetics; Polydipsia; Polymorphism; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE; COMT PROTEIN, HUMAN; DOPAMINE;

ADULT; ARTICLE; CHRONIC PATIENT; COMT GENE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; POLYDIPSIA; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; AGED; ALLELE; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; DRINKING BEHAVIOR; EPIDEMIOLOGY; GENETICS; HOSPITAL PATIENT; MIDDLE AGED; PHYSIOLOGY; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOPAMINE; DRINKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; POLYDIPSIA; POLYMORPHISM, SINGLE NUCLEOTIDE; SAMPLE SIZE; SCHIZOPHRENIA;

EID: 84901266211     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8287-9     Document Type: Article

References (38)

1. Assal, F., & Chauchot, F. (1994). Hyponatremia of therapeutic origin. Apropos of a case. Encephale, 20(5), 527-529.
2. Barnett, J. H., Scoriels, L., & Munafo, M. R. (2008). Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biological Psychiatry, 64(2), 137-144. doi: 10.1016/j.biopsych. 2008.01.005.
3. Canuso, C. M., & Goldman, M. B. (1999). Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 11(1), 86-90.
4. de Leon, J., Verghese, C., Stanilla, J. K., Lawrence, T., & Simpson, G. M. (1995). Treatment of polydipsia and hyponatremia in psychiatric patients. Can clozapine be a new option? Neuropsychopharmacology, 12(2), 133-138. doi: 10.1016/0893-133X(94)00069-C.
5. de Leon, J., Verghese, C., Tracy, J. I., Josiassen, R. C., & Simpson, G. M. (1994). Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature. Biological Psychiatry, 35(6), 408-419.
6. Delva, N. J., Crammer, J. L., Lawson, J. S., Lightman, S. L., Sribney, M., & Weier, B. J. (1990). Vasopressin in chronic psychiatric patients with primary polydipsia. British Journal of Psychiatry, 157, 703-712.
7. Dourish, C. T. (1983). Dopaminergic involvement in the control of drinking behaviour: A brief review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 7(4-6), 487-493.
8. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences, 98(12), 6917-6922. doi: 10.1073/pnas.111134598.
9. Ferrier, I. N. (1985). Water intoxication in patients with psychiatric illness. British Medical Journal (Clinical Research Ed), 291(6509), 1594-1596.
10. Fukunaka, Y., Shinkai, T., Hwang, R., Hori, H., Utsunomiya, K., Sakata, S., et al. (2007). The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia. Neuromolecular Medicine, 9(4), 292-297. doi: 10.1007/s12017-007-8001-2.
11. Fuller, M. A., Jurjus, G., Kwon, K., Konicki, P. E., & Jaskiw, G. E. (1996). Clozapine reduces water-drinking behavior in schizophrenic patients with polydipsia. Journal of Clinical Psychopharmacology, 16(4), 329-332.
12. Goldman, M. B., Luchins, D. J., & Robertson, G. L. (1988). Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. New England Journal of Medicine, 318(7), 397-403. doi: 10.1056/NEJM198802183180702.
13. Henderson, D. C., & Goff, D. C. (1994). Clozapine for polydipsia and hyponatremia in chronic schizophrenics. Biological Psychiatry, 36(11), 768-770.
14. Huotari, M., Garcia-Horsman, J. A., Karayiorgou, M., Gogos, J. A., & Mannisto, P. T. (2004). D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology (Berl), 172(1), 1-10. doi: 10.1007/s00213-003-1627-3.
15. Illowsky, B. P., & Kirch, D. G. (1988). Polydipsia and hyponatremia in psychiatric patients. American Journal of Psychiatry, 145(6), 675-683.
16. Jones, B. D. (1984). Psychosis associated with water intoxication: Psychogenic polydipsia or concomitant dopaminergic supersensitivity disorders? Lancet, 2(8401), 519-520.
17. Kishimoto, T., Hirai, M., Ohsawa, H., Terada, M., Matsuoka, I., & Ikawa, G. (1989). Manners of arginine vasopressin secretion in schizophrenic patients - with reference to the mechanism of water intoxication. The Japanese Journal of Psychiatry and Neurology, 43(2), 161-169.
18. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6(3), 243-250.
19. Lawson, W. B., Karson, C. N., & Bigelow, L. B. (1985). Increased urine volume in chronic schizophrenic patients. Psychiatry Research, 14(4), 323-331.
20. Matsumoto, C., Shinkai, T., De Luca, V., Hori, H., Hwang, R., Ohmori, O., et al. (2006). Association study between functional polymorphisms in the cytochrome P450 1A2 and 2D6 genes and polydipsia in schizophrenia. Neuromolecular Medicine, 8(3), 381-388. doi: 10.1385/NMM:8:3:381.
21. Mittleman, G., Rosner, A. L., & Schaub, C. L. (1994). Polydipsia and dopamine: Behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. Journal of Pharmacology and Experimental Therapeutics, 271(2), 638-650.
22. Owen, M. J. (2005). Genomic approaches to schizophrenia. Clinical Therapeutics, 27(Suppl A), S-2-S-7. doi: 10.1016/j.clinthera.2005.07.014.
23. Raskind, M. A., Orenstein, H., & Christopher, T. G. (1975). Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. American Journal of Psychiatry, 132(9), 907-910.
24. Sarai, M., & Matsunaga, H. (1989). ADH secretion in schizophrenic patients on antipsychotic drugs. Biological Psychiatry, 26(6), 576-580.
25. Shen, W. W., & Sata, L. S. (1983). Hypothalamic dopamine receptor supersensitivity? A pilot study of self-induced water intoxication. Psychiatric Journal of the University of Ottawa, 8(3), 154-158.
26. Shinkai, T., De Luca, V., Utsunomiya, K., Sakata, S., Inoue, Y., Fukunaka, Y., et al. (2008). Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia. Neuromolecular Medicine, 10(4), 362-367. doi: 10.1007/s12017-008-8041-2.
27. Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2003). Genetic approaches to polydipsia in schizophrenia: A preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 119B(1), 7-12. doi: 10.1002/ajmg.b.10066.
28. Silverstein, E., Sokoloff, L., Mickelsen, O., & Jay, G. E. (1961). Primary polydipsia and hydronephrosis in an inbred strain of mice. American Journal of Pathology, 38(2), 143-159.
29. Smith, W. O., & Clark, M. L. (1980). Self-induced water intoxication in schizophrenic patients. American Journal of Psychiatry, 137(9), 1055-1060.
30. Spears, N. M., Leadbetter, R. A., & Shutty, M. S, Jr. (1996). Clozapine treatment in polydipsia and intermittent hyponatremia. Journal of Clinical Psychiatry, 57(3), 123-128.
31. Spigset, O., & Hedenmalm, K. (1995). Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety, 12(3), 209-225.
32. Tan, H. Y., Chen, A. G., Chen, Q., Browne, L. B., Verchinski, B., Kolachana, B., et al. (2012). Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Molecular Psychiatry, 17(10), 1007-1016. doi: 10.1038/mp.2011.91.
33. Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994). Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review. Epilepsia, 35(1), 181-188.
34. Verghese, C., de Leon, J., & Josiassen, R. C. (1996). Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophrenia Bulletin, 22(3), 455-464.
35. Verghese, C., De Leon, J., & Simpson, G. M. (1993). Neuroendocrine factors influencing polydipsia in psychiatric patients: An hypothesis. Neuropsychopharmacology, 9(2), 157-166. doi: 10.1038/npp.1993.54.
36. Vieweg, W. V., David, J. J., Rowe, W. T., Peach, M. J., Veldhuis, J. D., & Spradlin, W. W. (1986). Correlation of cigarette-induced increase in serum nicotine levels with arginine vasopressin concentrations in the syndrome of self-induced water intoxication and psychosis (SIWIP). Canadian Journal of Psychiatry, 31(2), 108-111.
37. Wakefield, T., & Colls, I. (1996). Clozapine treatment of a schizophrenic patient with polydipsia and hyponatremia. American Journal of Psychiatry, 153(3), 445-446.
38. Yoshio, T., Inada, T., Uno, J., Miwa, T., Kitagawa, K., Miyahara, Y., et al. (2012). Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: Comparison between 2007 and 2009. Human Psychopharmacology, 27(1), 70-75. doi: 10.1002/hup.1272.